$CARA News Article - Enteris BioPharma's "Feasibil
Post# of 38
(Total Views: 409)
Posted On: 07/11/2019 12:25:40 PM
$CARA News Article - Enteris BioPharma's "Feasibility-to-Licensing" Partner, Cara Therapeutics, Initiates Phase 2 Trial of Peptelligence -Engineered Oral KORSUVA(TM) for Pruritus in Patients with Atopic Dermatitis https://marketwirenews.com/news-releases/ente...22664.html
(0)
(0)Cara Therapeutics, Inc. (CARA) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼